300 related articles for article (PubMed ID: 30665480)
61. Nail Psoriasis: A Systematic Evaluation in 313 Children with Psoriasis.
Pourchot D; Bodemer C; Phan A; Bursztejn AC; Hadj-Rabia S; Boralevi F; Miquel J; Hubiche T; Puzenat E; Souillet AL; Kupfer I; Piram M; Beauchet A; Mahé E;
Pediatr Dermatol; 2017 Jan; 34(1):58-63. PubMed ID: 27873356
[TBL] [Abstract][Full Text] [Related]
62. New insight into the pathogenesis of nail psoriasis and overview of treatment strategies.
Ventura A; Mazzeo M; Gaziano R; Galluzzo M; Bianchi L; Campione E
Drug Des Devel Ther; 2017; 11():2527-2535. PubMed ID: 28919705
[TBL] [Abstract][Full Text] [Related]
63. Clinical parameters associated with severity of nail psoriasis and therapeutic efficacy.
You Z; Yang H; Ran Y
Eur J Dermatol; 2020 Aug; 30(4):362-371. PubMed ID: 32969797
[TBL] [Abstract][Full Text] [Related]
64. The nail dystrophy of psoriatic arthritis.
Eastmond CJ; Wright V
Ann Rheum Dis; 1979 Jun; 38(3):226-8. PubMed ID: 485578
[TBL] [Abstract][Full Text] [Related]
65. Ultrasound entheseal abnormalities at the distal interphalangeal joints and clinical nail involvement in patients with psoriasis and psoriatic arthritis, supporting the nail-enthesitis theory.
Acosta-Felquer ML; Ruta S; Rosa J; Marin J; Ferreyra-Garrot L; Galimberti ML; Galimberti R; Garcia-Monaco R; Soriano ER
Semin Arthritis Rheum; 2017 Dec; 47(3):338-342. PubMed ID: 28648658
[TBL] [Abstract][Full Text] [Related]
66. [Association of skin lesion severity with clinical features of psoriatic arthritis].
Liu HL; He N; Dou L; Wang YH; Su JM; Li MT; Leng XM; Zeng XF
Zhonghua Nei Ke Za Zhi; 2022 Jul; 61(7):779-784. PubMed ID: 35764561
[No Abstract] [Full Text] [Related]
67. Ustekinumab in nail psoriasis: an open-label, uncontrolled, nonrandomized study.
Patsatsi A; Kyriakou A; Sotiriadis D
J Dermatolog Treat; 2013 Apr; 24(2):96-100. PubMed ID: 21797806
[TBL] [Abstract][Full Text] [Related]
68. Approach to managing patients with nail psoriasis.
Reich K
J Eur Acad Dermatol Venereol; 2009 Sep; 23 Suppl 1():15-21. PubMed ID: 19686381
[TBL] [Abstract][Full Text] [Related]
69. TNF-α antagonists and nail psoriasis: an open, 24-week, prospective cohort study in adult patients with psoriasis.
Saraceno R; Pietroleonardo L; Mazzotta A; Zangrilli A; Bianchi L; Chimenti S
Expert Opin Biol Ther; 2013 Apr; 13(4):469-73. PubMed ID: 23157654
[TBL] [Abstract][Full Text] [Related]
70. Nail Involvement as a Predictor of Disease Severity in Paediatric Psoriasis: Follow-up Data from the Dutch ChildCAPTURE Registry.
Bronckers IMGJ; Bruins FM; van Geel MJ; Groenewoud HMM; Kievit W; van de Kerkhof PCM; Pasch MC; de Jong EMGJ; Seyger MMB
Acta Derm Venereol; 2019 Feb; 99(2):152-157. PubMed ID: 30206638
[TBL] [Abstract][Full Text] [Related]
71. Nail psoriasis: a retrospective study on the effectiveness of systemic treatments (classical and biological therapy).
Sánchez-Regaña M; Sola-Ortigosa J; Alsina-Gibert M; Vidal-Fernández M; Umbert-Millet P
J Eur Acad Dermatol Venereol; 2011 May; 25(5):579-86. PubMed ID: 21198950
[TBL] [Abstract][Full Text] [Related]
72. Nail psoriasis: a review.
Tan ES; Chong WS; Tey HL
Am J Clin Dermatol; 2012 Dec; 13(6):375-88. PubMed ID: 22784035
[TBL] [Abstract][Full Text] [Related]
73. Nail Psoriasis Improvement During Tildrakizumab Therapy: A Real-Life Experience.
Brunasso A
J Drugs Dermatol; 2022 Aug; 21(8):914-916. PubMed ID: 35946963
[TBL] [Abstract][Full Text] [Related]
74. Clinical study of psoriasis occurring over the age of 60 years: is elderly-onset psoriasis a distinct subtype?
Kwon HH; Kwon IH; Youn JI
Int J Dermatol; 2012 Jan; 51(1):53-8. PubMed ID: 22182378
[TBL] [Abstract][Full Text] [Related]
75. The evaluation of the sociodemographic and clinical features of Turkish psoriasis patients.
Kundakci N; Türsen U; Babiker MO; Gürgey E
Int J Dermatol; 2002 Apr; 41(4):220-4. PubMed ID: 12031031
[TBL] [Abstract][Full Text] [Related]
76. NAPSI utilization as an evaluation method of nail psoriasis in patients using acitretin.
Mukai MM; Poffo IF; Werner B; Brenner FM; Lima Filho JH
An Bras Dermatol; 2012; 87(2):256-62. PubMed ID: 22570030
[TBL] [Abstract][Full Text] [Related]
77. In psoriasis treatment, greater improvement in skin severity predicts greater improvement in nail severity.
Rusk AM; Fleischer AB
J Dermatolog Treat; 2021 Dec; 32(8):894-897. PubMed ID: 31971034
[TBL] [Abstract][Full Text] [Related]
78. Ultrasound nail imaging on patients with psoriasis and psoriatic arthritis compared with rheumatoid arthritis and control subjects.
Sandobal C; Carbó E; Iribas J; Roverano S; Paira S
J Clin Rheumatol; 2014 Jan; 20(1):21-4. PubMed ID: 24356473
[TBL] [Abstract][Full Text] [Related]
79. Ultrasonographic assessment of nail in psoriatic disease shows a link between onychopathy and distal interphalangeal joint extensor tendon enthesopathy.
Aydin SZ; Castillo-Gallego C; Ash ZR; Marzo-Ortega H; Emery P; Wakefield RJ; Wittmann M; McGonagle D
Dermatology; 2012; 225(3):231-5. PubMed ID: 23128597
[TBL] [Abstract][Full Text] [Related]
80. Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire.
Barrea L; Macchia PE; Tarantino G; Di Somma C; Pane E; Balato N; Napolitano M; Colao A; Savastano S
J Transl Med; 2015 Sep; 13():303. PubMed ID: 26376719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
